VEGFA and non-small cell lung carcinoma: BMS-690514 is a potent inhibitor of the epidermal growth factor (EGF) receptor (HER)/vascular endothelial growth factor (VEGFR) receptor and exerts anti-apoptotic effects by decreasing the expression of HSP40 and other HSPs in non-small-cell lung cancer (NSCLC) cells [94,95].